Cargando...
Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma
We report a case showing the long-term clinical benefit of the continued use of gefitinib in a patient with asymptomatic progression of lung adenocarcinoma harboring an exon 19 deletion of the epidermal growth factor receptor gene. Although follow-up studies showed smoldering progression of metastat...
Gardado en:
| Publicado en: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BlackWell Publishing Ltd
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4448482/ https://ncbi.nlm.nih.gov/pubmed/26273363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12171 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|